Heartgard Plus chewable tablets

Heartgard is a leading veterinary medication brand used globally to prevent heartworm disease and treat various intestinal parasites in dogs and cats. Originally developed as a breakthrough in animal health, the product utilizes Ivermectin and Pyrantel to ensure the safety and wellbeing of pets. It has long been a staple in veterinary clinics and is widely recognized for its chewable format which improves ease of administration for pet owners.

The brand's history is tied to the evolution of major animal health corporations. Initially part of the Merck & Co. portfolio and later Merial (a joint venture between Merck and Sanofi), the brand is now under the stewardship of Boehringer Ingelheim. This transition followed a multi-billion dollar asset swap that solidified Boehringer Ingelheim's position as a global leader in the animal health sector. Manufacturing primarily takes place in specialized facilities in the United States to meet rigorous FDA and international pharmaceutical standards.

Today, Heartgard remains a flagship product for Boehringer Ingelheim Animal Health. The company continues to invest in the research and development of the brand, maintaining its status as one of the most trusted names in preventative pet care. The ultimate ownership resides in Germany, where the parent company manages its worldwide operations across both human and animal medicine sectors.